Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
NEW DELHI, March 20, 2026 Indian pharmaceutical companies are stepping up efforts to introduce more affordable versions of semaglutide, a widely used treatment for type 2 diabetes and obesity, as interest in the therapy grows globally
Important caveat: there are no completed human clinical trials of 5-Amino-1MQ
Tianyuan successively passed the GMP inspection audits from southeast Asia, the Middle East, Africa, and many other countries and regions, and the products are sold to many countries and regions around the world
Takes Time to See Results Most people notice real changes in 8 to 12 weeks
If you used semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) for weight loss and did not see good changes, there may be another option for you
US$ 26.31
US$ 22.58
US$ 25.29
US$ 24.18
US$ 25.58
US$ 24.40
US$ 28.66
US$ 22.94
US$ 22.82
